EUVIMEDEUVIMED entdecken
Crossref

Economic Impact of a Diabetes Disease Management Program in a Self-Insured Health Plan: Early Results

Jan Berger, Julie Slezak, Neal Stine, Pat McStay, Bill O'Leary, Joseph Addiego

Disease Management · 2001

DOI: 10.1089/10935070152404252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Management, 2001. Verfasst von Jan Berger und 5 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disease management has grown to a $350 million industry with over 100 providers. Delivery models vary among providers, but short-term economic outcomes are the standard by which a program's success is generally measured. This report focuses on a large self-insured organization that offered the CarePatterns® Disease Management Program for diabetes. Individuals with diabetes were identified by pharmacy claims and invited to participate. Enrollment was voluntary (n = 2745). Medical claims history of eligible individuals who chose not to participate (control group) was used to understand the progress of these chronic diseases in the absence of intervention (n = 8978). Standard forecasting methods using medical claims data from 1997 and 1998 were used for spending projections. The study period ran from 1/1/1997 through 12/31/1999. Evaluation of 24 months of medical claims data showed that participants in the program had higher direct healthcare costs than nonparticipants. Actual medical expenditures for participants decreased by $747 (9.4%) from the baseline period (1998). When participants' 1999 actual spending is compared to 1999 projected medical spending, savings are $1474 (17%) per participant. Conversely, nonparticipant control medical spending increased by $230 (3.3%) per individual. Pharmacy spending for participants increased 23.5% from Baseline to 1999. For nonparticipant controls, pharmacy spending increased by 19.7%. Although further analysis is required to determine which component of interventions significantly contributed, an effective patient-focused disease management program is an important factor in promoting the appropriate use of pharmaceuticals and medical resource utilization.

Zitieren

APA

Berger, J., Slezak, J., Stine, N., McStay, P., O'Leary, B., & Addiego, J. (2001). Economic Impact of a Diabetes Disease Management Program in a Self-Insured Health Plan: Early Results. Disease Management. https://doi.org/10.1089/10935070152404252

Vancouver

Berger J, Slezak J, Stine N, McStay P, O'Leary B, Addiego J. Economic Impact of a Diabetes Disease Management Program in a Self-Insured Health Plan: Early Results. Disease Management. 2001. doi:10.1089/10935070152404252

BibTeX
@article{Berger2001,
  author = {Berger, Jan and Slezak, Julie and Stine, Neal and McStay, Pat and O'Leary, Bill and Addiego, Joseph},
  title = {Economic Impact of a Diabetes Disease Management Program in a Self-Insured Health Plan: Early Results},
  journal = {Disease Management},
  year = {2001},
  doi = {10.1089/10935070152404252}
}
Kostenlos starten →